Funded Tech Companies
K36 Therapeutics
K36 Therapeutics, operating out of Cambridge, has financial backing from Atlas Venture, F-Prime Capital and Eight Roads.
Company Overview
Company Name
K36 Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Main St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
K36's lead candidate is KTX-1001, a first-in-class, selective inhibitor of the histone methyltransferase (HMT) MMSET, which is overexpressed in up to 20% of multiple myeloma patients due to the t(4;14) translocation.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/10/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Terry Connolly
Vice President
Travis Quigley
VP - Manufacturing
Chad Lewis
VP - Operations
Bao-Van Linberg
Company Investors
- Atlas Venture (Jason Rhodes)
- F-Prime Capital (Chong Xu)
- Eight Roads
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs